234 related articles for article (PubMed ID: 24260029)
1. When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa.
Schomaker M; Egger M; Ndirangu J; Phiri S; Moultrie H; Technau K; Cox V; Giddy J; Chimbetete C; Wood R; Gsponer T; Bolton Moore C; Rabie H; Eley B; Muhe L; Penazzato M; Essajee S; Keiser O; Davies MA;
PLoS Med; 2013 Nov; 10(11):e1001555. PubMed ID: 24260029
[TBL] [Abstract][Full Text] [Related]
2. Growth and Mortality Outcomes for Different Antiretroviral Therapy Initiation Criteria in Children Ages 1-5 Years: A Causal Modeling Analysis.
Schomaker M; Davies MA; Malateste K; Renner L; Sawry S; N'Gbeche S; Technau KG; Eboua F; Tanser F; Sygnaté-Sy H; Phiri S; Amorissani-Folquet M; Cox V; Koueta F; Chimbete C; Lawson-Evi A; Giddy J; Amani-Bosse C; Wood R; Egger M; Leroy V;
Epidemiology; 2016 Mar; 27(2):237-46. PubMed ID: 26479876
[TBL] [Abstract][Full Text] [Related]
3. Optimal timing of antiretroviral treatment initiation in HIV-positive children and adolescents: a multiregional analysis from Southern Africa, West Africa and Europe.
Schomaker M; Leroy V; Wolfs T; Technau KG; Renner L; Judd A; Sawry S; Amorissani-Folquet M; Noguera-Julian A; Tanser F; Eboua F; Navarro ML; Chimbetete C; Amani-Bosse C; Warszawski J; Phiri S; N'Gbeche S; Cox V; Koueta F; Giddy J; Sygnaté-Sy H; Raben D; Chêne G; Davies MA;
Int J Epidemiol; 2017 Apr; 46(2):453-465. PubMed ID: 27342220
[TBL] [Abstract][Full Text] [Related]
4. Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study.
Picat MQ; Lewis J; Musiime V; Prendergast A; Nathoo K; Kekitiinwa A; Nahirya Ntege P; Gibb DM; Thiebaut R; Walker AS; Klein N; Callard R;
PLoS Med; 2013 Oct; 10(10):e1001542. PubMed ID: 24204216
[TBL] [Abstract][Full Text] [Related]
5. Time-varying age- and CD4-stratified rates of mortality and WHO stage 3 and stage 4 events in children, adolescents and youth 0 to 24 years living with perinatally acquired HIV, before and after antiretroviral therapy initiation in the paediatric IeDEA Global Cohort Consortium.
Desmonde S; Neilan AM; Musick B; Patten G; Chokephaibulkit K; Edmonds A; Duda SN; Malateste K; Wools-Kaloustian K; Ciaranello AL; Davies MA; Leroy V;
J Int AIDS Soc; 2020 Oct; 23(10):e25617. PubMed ID: 33034417
[TBL] [Abstract][Full Text] [Related]
6. Optimal time for initiating antiretroviral therapy (ART) in HIV-infected, treatment-naive children aged 2 to 5 years old.
Siegfried N; Davies MA; Penazzato M; Muhe LM; Egger M
Cochrane Database Syst Rev; 2013 Oct; 10(10):CD010309. PubMed ID: 24114324
[TBL] [Abstract][Full Text] [Related]
7. Temporal trends in the characteristics of children at antiretroviral therapy initiation in southern Africa: the IeDEA-SA Collaboration.
Davies MA; Phiri S; Wood R; Wellington M; Cox V; Bolton-Moore C; Timmerman V; Moultrie H; Ndirangu J; Rabie H; Technau K; Giddy J; Maxwell N; Boulle A; Keiser O; Egger M; Eley B;
PLoS One; 2013; 8(12):e81037. PubMed ID: 24363808
[TBL] [Abstract][Full Text] [Related]
8. Global temporal changes in the proportion of children with advanced disease at the start of combination antiretroviral therapy in an era of changing criteria for treatment initiation.
Panayidou K; Davies MA; Anderegg N; Egger M;
J Int AIDS Soc; 2018 Nov; 21(11):e25200. PubMed ID: 30614622
[TBL] [Abstract][Full Text] [Related]
9. Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults.
Siegfried N; Uthman OA; Rutherford GW
Cochrane Database Syst Rev; 2010 Mar; 2010(3):CD008272. PubMed ID: 20238364
[TBL] [Abstract][Full Text] [Related]
10. Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study.
Cornell M; Schomaker M; Garone DB; Giddy J; Hoffmann CJ; Lessells R; Maskew M; Prozesky H; Wood R; Johnson LF; Egger M; Boulle A; Myer L;
PLoS Med; 2012; 9(9):e1001304. PubMed ID: 22973181
[TBL] [Abstract][Full Text] [Related]
11. Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies.
Johnson LF; Mossong J; Dorrington RE; Schomaker M; Hoffmann CJ; Keiser O; Fox MP; Wood R; Prozesky H; Giddy J; Garone DB; Cornell M; Egger M; Boulle A;
PLoS Med; 2013; 10(4):e1001418. PubMed ID: 23585736
[TBL] [Abstract][Full Text] [Related]
12. When to start antiretroviral therapy in resource-limited settings.
Walensky RP; Wolf LL; Wood R; Fofana MO; Freedberg KA; Martinson NA; Paltiel AD; Anglaret X; Weinstein MC; Losina E;
Ann Intern Med; 2009 Aug; 151(3):157-66. PubMed ID: 19620143
[TBL] [Abstract][Full Text] [Related]
13. Earlier Antiretroviral Therapy Initiation and Decreasing Mortality Among HIV-infected Infants Initiating Antiretroviral Therapy Within 3 Months of Age in South Africa, 2006-2017.
Iyun V; Technau KG; Eley B; Rabie H; Boulle A; Fatti G; Egger M; Tanser F; Wood R; Fairlie L; Cotton MF; Davies MA
Pediatr Infect Dis J; 2020 Feb; 39(2):127-133. PubMed ID: 31725119
[TBL] [Abstract][Full Text] [Related]
14. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.
; Sterne JA; May M; Costagliola D; de Wolf F; Phillips AN; Harris R; Funk MJ; Geskus RB; Gill J; Dabis F; Miró JM; Justice AC; Ledergerber B; Fätkenheuer G; Hogg RS; Monforte AD; Saag M; Smith C; Staszewski S; Egger M; Cole SR
Lancet; 2009 Apr; 373(9672):1352-63. PubMed ID: 19361855
[TBL] [Abstract][Full Text] [Related]
15. Access to antiretroviral therapy in HIV-infected children aged 0-19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004-2015: A prospective cohort study.
Desmonde S; Tanser F; Vreeman R; Takassi E; Edmonds A; Lumbiganon P; Pinto J; Malateste K; McGowan C; Kariminia A; Yotebieng M; Dicko F; Yiannoutsos C; Mubiana-Mbewe M; Wools-Kaloustian K; Davies MA; Leroy V;
PLoS Med; 2018 May; 15(5):e1002565. PubMed ID: 29727458
[TBL] [Abstract][Full Text] [Related]
16. Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies.
Boulle A; Schomaker M; May MT; Hogg RS; Shepherd BE; Monge S; Keiser O; Lampe FC; Giddy J; Ndirangu J; Garone D; Fox M; Ingle SM; Reiss P; Dabis F; Costagliola D; Castagna A; Ehren K; Campbell C; Gill MJ; Saag M; Justice AC; Guest J; Crane HM; Egger M; Sterne JA
PLoS Med; 2014 Sep; 11(9):e1001718. PubMed ID: 25203931
[TBL] [Abstract][Full Text] [Related]
17. Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis.
Haas AD; Keiser O; Balestre E; Brown S; Bissagnene E; Chimbetete C; Dabis F; Davies MA; Hoffmann CJ; Oyaro P; Parkes-Ratanshi R; Reynolds SJ; Sikazwe I; Wools-Kaloustian K; Zannou DM; Wandeler G; Egger M;
Lancet HIV; 2015 Jul; 2(7):e271-8. PubMed ID: 26423252
[TBL] [Abstract][Full Text] [Related]
18. Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa.
Fenner L; Brinkhof MW; Keiser O; Weigel R; Cornell M; Moultrie H; Prozesky H; Technau K; Eley B; Vaz P; Pascoe M; Giddy J; Van Cutsem G; Wood R; Egger M; Davies MA;
J Acquir Immune Defic Syndr; 2010 Aug; 54(5):524-32. PubMed ID: 20588185
[TBL] [Abstract][Full Text] [Related]
19. HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countries.
Tymejczyk O; Brazier E; Yiannoutsos C; Wools-Kaloustian K; Althoff K; Crabtree-Ramírez B; Van Nguyen K; Zaniewski E; Dabis F; Sinayobye JD; Anderegg N; Ford N; Wikramanayake R; Nash D;
PLoS Med; 2018 Mar; 15(3):e1002534. PubMed ID: 29570723
[TBL] [Abstract][Full Text] [Related]
20. Discordance between CD4 cell count and CD4 cell percentage: implications for when to start antiretroviral therapy in HIV-1 infected children.
; Boyd K; Dunn DT; Castro H; Gibb DM; Duong T; Aboulker JP; Bulterys M; Cortina-Borja M; Gabiano C; Galli L; Giaquinto C; Harris DR; HugheS M; McKinney R; Mofenson L; Moye J; Newell ML; Pahwa S; Palumbo P; Rudin C; Sharland M; Shearer W; Thompson B; Tookey P
AIDS; 2010 May; 24(8):1213-7. PubMed ID: 20386428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
